Lillys triple agonist retatrutide delivered weight loss of up to an average of 71.2 lbs in first successful Phase 3 trial. Retrieved 2026-07-03
Reduce UV-induced cellular damage (sunburn cells)
That work led to the discovery of glucagon-like peptide-1 (GLP-1), a hormone released from the small intestine that helps control insulin secretion, slow digestion and reduce appetite
The study was randomized (1:1:1:1: placebo
People considering GLP-1 treatments often worry about rare side effects, such as increased risk of thyroid cancer, "but gallstones happen in a decent subset of these patients," says Armen Yerevanian, an endocrinologist at Massachusetts General Hospital
George Bolotin, is a vascular specialist in Brooklyn, NY and a renowned interventional radiologist with extensive experience in hemorrhoid embolization procedures